ARHS
Arhaus, Inc.
ARHS has a slight edge over LCID overall on the model score.
LCID
Lucid Group, Inc.
LCID offers stronger valuation, but that advantage does not outweigh its weaker overall profile.
ARHS Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Stable | |
| Healthy | |
| Strong |
ARHS's cash flow and balance sheet are currently healthy, and its revenue and profitability are stable.
LCID Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Weak | |
| Weak | |
| Unavailable |
LCID's revenue is currently healthy, but its profitability and cash flow are weak. There isn't enough data to rate its balance sheet.
ARHS PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 10x | $4.81 | -64% |
| Fair | 18x | $8.20 | -39% |
| Expensive | 22x | $10.24 | -24% |
| Forward | 24x | $13.52 | — |
| Current | 29x | $13.52 | — |
Historical ranges are pointers, not guarantees.
ARHS's PE is in its expensive range at 29x. If earnings grow as analysts expect, today's price would be 24x next year's earnings.
LCID PE Valuation
LCID has no meaningful PE right now: it lost money over the past year.
ARHS Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Strong growth | |
| Growth | |
| Improving | |
| Limited | |
| Low |
Analysts expect earnings and revenue growth for ARHS, with profitability improving. However, they disagree widely on these estimates.
LCID Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Strong growth | |
| -- | |
| Limited | |
| Low |
Analysts expect LCID's losses to shrink, with revenue growing. However, they disagree widely on these estimates.
ARHS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $0.56 | +22% |
| Q3 2026 | $0.46 | -12% |
| Q2 2026 | $0.50 | 0% |
| Q1 2026 | $0.47 | +15% |
| Q4 2025 | $0.48 | -2% |
| Q3 2025 | $0.52 | -7.1% |
| Q2 2025 | $0.50 | -21% |
| Q1 2025 | $0.41 | -46% |
| Q4 2024 | $0.49 | -45% |
ARHS has the edge over LCID on earnings quality, reporting a profit while its opponent remains loss making.
LCID Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$13.08 | -$2.57 |
| Q2 2026 | -$13.65 | -$2.35 |
| Q1 2026 | -$13.15 | -$1.25 |
| Q4 2025 | -$12.09 | +$0.41 |
| Q3 2025 | -$10.51 | +$2.49 |
| Q2 2025 | -$11.30 | +$0.40 |
| Q1 2025 | -$11.90 | +$0.40 |
| Q4 2024 | -$12.50 | +$1.10 |
LCID is still losing money, but less than at its worst: $13.08 per share over the past year, against $16.50 at its worst in mid-2023.
ARHS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $368.1M | +6.8% |
| Q2 2026 | $384.9M | +7.4% |
| Q1 2026 | $314.3M | +0.9% |
| Q4 2025 | $364.8M | +5.1% |
| Q3 2025 | $344.6M | +8% |
| Q2 2025 | $358.4M | +16% |
| Q1 2025 | $311.4M | +5.5% |
| Q4 2024 | $347M | +0.9% |
ARHS's revenue has grown year over year for eight quarters in a row: $368M last quarter, up 6.8% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 2.7% | -2 points |
| Q2 2026 | 14% | +1 points |
| Q1 2026 | 0.7% | -1.1 points |
| Q4 2025 | 5.5% | -2.7 points |
| Q3 2025 | 4.8% | +1.4 points |
| Q2 2025 | 13% | +3.6 points |
| Q1 2025 | 1.7% | -4.5 points |
| Q4 2024 | 8.2% | -3.7 points |
ARHS has the edge over LCID on profitability, with a higher operating margin.
LCID Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $350.3M | +4.1% |
| Q2 2026 | $405.3M | +56% |
| Q1 2026 | $282.5M | +20% |
| Q4 2025 | $522.7M | +123% |
| Q3 2025 | $336.6M | +68% |
| Q2 2025 | $259.4M | +29% |
| Q1 2025 | $235M | +36% |
| Q4 2024 | $234.5M | +49% |
LCID has the edge over ARHS on sales, with stronger typical year-over-year growth.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -245% | +35 points |
| Q2 2026 | -267% | +43 points |
| Q1 2026 | -350% | -56 points |
| Q4 2025 | -204% | +109 points |
| Q3 2025 | -280% | +105 points |
| Q2 2025 | -310% | +83 points |
| Q1 2025 | -294% | +128 points |
| Q4 2024 | -313% | +156 points |
LCID's operating margin was −245% last quarter, up 35 points from the same quarter a year ago, near the top of its range since 2020.
ARHS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $91.9M | +228% |
| Q2 2026 | $48.3M | +131% |
| Q1 2026 | -$26.6M | -241% |
| Q4 2025 | -$8.8M | -168% |
| Q3 2025 | $28M | +509% |
| Q2 2025 | $20.9M | +86% |
| Q1 2025 | $18.9M | +73% |
| Q4 2024 | $13M | +$26.8M |
ARHS has the edge over LCID on cash generation, producing positive trailing cash flow while its opponent burns cash.
LCID Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$1B | -$84.2M |
| Q2 2026 | -$1.5B | -$463.2M |
| Q1 2026 | -$1.4B | -$849M |
| Q4 2025 | -$1.2B | -$417.1M |
| Q3 2025 | -$955.5M | -$333M |
| Q2 2025 | -$1B | -$271.6M |
| Q1 2025 | -$589.9M | +$125.1M |
| Q4 2024 | -$824.8M | -$77.6M |
LCID has burned cash in almost every quarter: −$5.2B over the past year, against −$3.4B the year before.
ARHS Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.3% | +467K shares |
| 1 year | +0.4% | +598K shares |
| 3 years | +1.5% | +2.1M shares |
| 5 years | +27% | +30.2M shares |
| Available history | +401% | +114M shares |
ARHS has the edge over LCID on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q4 2021 | — |
| Q2 2021 | — |
| Q1 2021 | — |
| Q4 2020 | — |
| Q3 2020 | — |
| Q2 2020 | $50,000 |
| Q1 2020 | $50,000 |
LCID Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +3.3% | +12.5M shares |
| 1 year | +26% | +82.4M shares |
| 3 years | +73% | +166M shares |
LCID has 395M diluted shares, up 26% from a year ago.
| Quarter | Spent |
|---|---|
| Q4 2020 | $2.2M |
| Q1 2020 | — |
ARHS Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -2.3x | Net Cash |
| Q2 2026 | -1.6x | Net Cash |
| Q1 2026 | -1.3x | Net Cash |
| Q4 2025 | -1.9x | Net Cash |
| Q3 2025 | -1.8x | Net Cash |
| Q2 2025 | -1.7x | Net Cash |
| Q1 2025 | -1.9x | Net Cash |
| Q4 2024 | -1.6x | Net Cash |
ARHS has more cash than debt.
LCID Net Leverage
LCID's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
ARHS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 69.0 | Neutral |
| Stochastic | 90.6 | Overbought |
ARHS's weekly RSI is 69 (neutral) and its Stochastic is 91 (overbought).
LCID Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 32.9 | Neutral |
| Stochastic | 7.1 | Oversold |
LCID's weekly RSI is 33 (neutral) and its Stochastic is 7 (oversold).
ARHS PE vs Consumer Cyclical Sector
| Metric | ARHS | Sector median | Relative |
|---|---|---|---|
| PE | 29x | 18x | 63% above |
| PE % | 96 | 56 | 40 pts above |
ARHS is trading at 29x earnings, a 63% premium to the Consumer Cyclical sector's median of 18x.
LCID PE vs Consumer Cyclical Sector
LCID has no meaningful PE right now: it lost money over the past year.
ARHS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $11.4 | 18% above |
| 20 week MA | $9.67 | 40% above |
| 50 week MA | $8.97 | 51% above |
| 100 week MA | $9.41 | 44% above |
| 200 week MA | $10.5 | 29% above |
ARHS has the edge over LCID on trend strength, trading above more of its moving averages.
LCID Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $3.53 | 7.9% below |
| 20 week MA | $4.88 | 33% below |
| 50 week MA | $7.33 | 56% below |
| 100 week MA | $15.4 | 79% below |
| 200 week MA | $31.9 | 90% below |
LCID is in a downtrend: it's below all five of its weekly moving averages, and 90% below its 200-week average.
ARHS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2021 | $12.2 | $10.4 | -15% |
| 2022 | $10.4 | $9.24 | -11% |
| 2023 | $9.24 | $11.9 | +28% |
| 2024 | $11.9 | $9.26 | -22% |
| 2025 | $9.26 | $11.7 | +27% |
| 2026 YTD | $11.7 | $13.5 | +15% |
ARHS has the edge over LCID on returns for 2026, with the stronger performance.
LCID Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $98.9 | $100.4 | +1.5% |
| 2021 | $100.4 | $376.4 | +275% |
| 2022 | $376.4 | $67.0 | -82% |
| 2023 | $67.0 | $42.1 | -37% |
| 2024 | $42.1 | $32.0 | -24% |
| 2025 | $32.0 | $11.4 | -64% |
| 2026 YTD | $11.4 | $3.25 | -72% |
LCID has finished four years in a row lower, and it's down 72% so far in 2026.